04:30 PM, 6th Feb 2026
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the standalone and consolidated unaudited Financial result of the company for the quarter and nine months ended December 31 2025.